Efficacy and Safety of Etanercept in Psoriasis/Psoriatic ArthritisAn Updated Review

被引:0
作者
Alberto Romero-Maté
Carmen García-Donoso
Susana Córdoba-Guijarro
机构
[1] Service of Dermatology,
[2] Fuenlabrada Hospital,undefined
来源
American Journal of Clinical Dermatology | 2007年 / 8卷
关键词
Psoriasis; Etanercept; Dermatology Life Quality Index; Acitretin; Radiologic Progression;
D O I
暂无
中图分类号
学科分类号
摘要
The introduction in recent years of biologic medicines has greatly changed the treatment of psoriasis and psoriatic arthropathy (PsA). These drugs have been effective in the treatment of these chronic, physically weakening disorders, offering good efficacy and a safety profile that differs from those of all other systemic therapies and medications available to date.
引用
收藏
页码:143 / 155
页数:12
相关论文
共 144 条
  • [1] Gelfand JM(2005)Prevalence and treatment of psoriasis in the United Kingdom: a population-based study Arch Dermatol 141 1537-41
  • [2] Weinstein R(2003)Psoriasis Lancet 361 1197-204
  • [3] Porter SB(2005)Psoriatic arthritis therapy: NSAIDs and traditional DMARDs Ann Rheum Dis 64 74-7
  • [4] Lebowhl M(2003)Etanercept as monotherapy in patients with psoriasis N Engl J Med 349 2014-22
  • [5] Nash P(2003)A randomized trial of etanercept as monotherapy for psoriasis Arch Dermatol 139 1627-32
  • [6] Clegg CO(2005)A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction Br J Dermatol 152 1304-12
  • [7] Leonardi CL(2000)Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial Lancet 356 385-90
  • [8] Powers JL(2002)Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis Drugs 62 2493-537
  • [9] Matheson RT(1999)Cytokines in psoriasis Int J Dermatol 38 241-51
  • [10] Gottlieb AB(2006)Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients J Am Acad Dermatol 55 590-7